| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2009 | CN100453116C Process for preparing compound aminophylline tablet |
| 01/21/2009 | CN100453106C Chinese medicine compound preparation for treating laryngopharyngitis and tonsillitis and its preparing method |
| 01/21/2009 | CN100453097C Composite medicine for coronary heart disease and angina pectoris and its preparation |
| 01/21/2009 | CN100453092C Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue |
| 01/21/2009 | CN100453086C Gel for removing ocular by ice pearl and its preparation |
| 01/21/2009 | CN100453083C Dextran iron dispersing agent and its prepn. method |
| 01/21/2009 | CN100453082C Compound terbinafine and root of large flowered skullcap cream and its preparing method |
| 01/21/2009 | CN100453081C Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 01/21/2009 | CN100453080C Lindera root alkaloid, its preparation method and application in medicine preparation |
| 01/21/2009 | CN100453079C Water-soluble liquid internal medicine |
| 01/21/2009 | CN100453078C Method for treating primary insomnia |
| 01/21/2009 | CN100453077C Injectable micelle prepn containing garcinolic acid and its prepn process |
| 01/21/2009 | CN100453076C Application of phenhexyl isothiocyanate in preparation of medicament for treating leukemia |
| 01/21/2009 | CN100453075C Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent |
| 01/21/2009 | CN100453074C Sustained release drug delivery device |
| 01/21/2009 | CN100453071C Oral resveratrol multi-phase liposome and preparation method thereof |
| 01/21/2009 | CN100453069C Biphenyl diester emulsion and its preparing method |
| 01/21/2009 | CN100453068C Injection containing caderfloxacin lactate |
| 01/21/2009 | CN100453067C Preparation of injectable suspensions having improved injectabity |
| 01/21/2009 | CN100453066C Drug delivery system using subconjunctival depot |
| 01/21/2009 | CN100452984C Aimal growth regulating composition and its prepn and use |
| 01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 01/20/2009 | US7479572 Solvent system comprising isopropyl alcohol, water and toluene; recrystallization production of pure, thermodynamically stable form; long lasting bronchodilating effect |
| 01/20/2009 | US7479571 Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479563 Method of producing polymorphic crystals of donepezil hydrochloride |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479536 Chiral, charged peptide nucleic acid oligomers from cyclic monomers |
| 01/20/2009 | US7479535 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation |
| 01/20/2009 | US7479508 Nimesulide containing topical pharmaceutical compositions |
| 01/20/2009 | US7479507 Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs |
| 01/20/2009 | US7479506 administering a formulation comprising 2-oxo-1-pyrrolidineacetamide (piracetam) as an active ingredient and a pharmaceutically acceptable carrier for treating aphasia stage when no expectation of improvement in symptoms after at least 3 years of language rehabilitation |
| 01/20/2009 | US7479505 Administering taurolidine, taurultam, or a biologically active derivative to mammal to directly contact tumor cell at dosage sufficient to induce cell death by apoptosis; side effect reduction |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479503 Such as multiple sclerosis; also inactivating HIV virus via extracorporeal treatment of blood; use of a green porphyrin or porfimer sodium |
| 01/20/2009 | US7479502 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | US7479500 Antidepressant piperidine derivatives of heterocyclefused benzodioxans |
| 01/20/2009 | US7479499 Methods of using thalidomide in combination with irinotecan |
| 01/20/2009 | US7479498 Treatments for viral infections |
| 01/20/2009 | US7479497 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies |
| 01/20/2009 | US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
| 01/20/2009 | US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/20/2009 | US7479493 e.g. [4-(3,4-Dichloro-phenoxy)-3-methylaminomethyl-phenyl]-(4-isopropyl-piperazin-1-yl)-methanone; histamine H3 receptor and/or serotonin transporter modulator; antidepressant; cognitive disorders, sleep disorders, psychiatric disorders, drug abuse, sexual dysfunction |
| 01/20/2009 | US7479492 Use combined 5-HT1A agonists and selective serotonin reuptake inhibitors |
| 01/20/2009 | US7479491 Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors |
| 01/20/2009 | US7479490 pellets comprising resazurin, anhydrous sodium sulfate, 1-hydroxyethylidene biphosphonate, tetrasodium salt and magnesium stearate |
| 01/20/2009 | US7479489 Heterocyclic antiviral compounds |
| 01/20/2009 | US7479488 Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions |
| 01/20/2009 | US7479486 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids |
| 01/20/2009 | US7479485 Method of treating arrhythmias |
| 01/20/2009 | US7479483 Tumor-targeted drug delivery systems and uses thereof |
| 01/20/2009 | US7479476 Antimicrobial compositions comprising polymeric stabilizers |
| 01/20/2009 | US7479376 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 01/20/2009 | US7479286 Microbiocides fatty acid mixed with feed |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | US7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/20/2009 | CA2586146C Fluorocarbon aerosol medicaments |
| 01/20/2009 | CA2528493C Medicinal composition containing triazole compound |
| 01/20/2009 | CA2521030C 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2468916C A stable oxaliplatin solution formulation |
| 01/20/2009 | CA2465871C Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2445519C Method for manufacturing a low dose pharmaceutical composition |
| 01/20/2009 | CA2444116C Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 01/20/2009 | CA2432172C An in vivo method for producing female offsprings in mammals |
| 01/20/2009 | CA2423252C Photosensitisers |
| 01/20/2009 | CA2423020C Use of antiprogestins for the induction of apoptosis in a cell |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2396678C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/20/2009 | CA2393518C Amycomycin, a process for its production and its use as a pharmaceutical |
| 01/20/2009 | CA2391239C Benzopyran derivative and antiallergic agent |
| 01/20/2009 | CA2383916C Dispersion formulations containing lipase inhibitors |
| 01/20/2009 | CA2383241C Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 01/20/2009 | CA2376676C Respiratory syncytial virus replication inhibitors |
| 01/20/2009 | CA2373484C Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2366268C Pharmaceutical compositions for cns and other disorders |
| 01/20/2009 | CA2365240C Regulation of phospholipase d activity |
| 01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
| 01/20/2009 | CA2355644C Controlled/modified release oral methylphenidate formulations |
| 01/20/2009 | CA2352762C Oral transmucosal delivery |
| 01/20/2009 | CA2352389C An oral formulation for gastrointestinal drug delivery |
| 01/20/2009 | CA2348759C Gel compositions |
| 01/20/2009 | CA2344411C 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/20/2009 | CA2339961C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 01/20/2009 | CA2339193C Pharmaceutical compositions comprising ibuprofen and domperidone |
| 01/20/2009 | CA2338794C New oral formulation for 5-ht4 agonists or antagonists |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2327495C Form vi 5,6-dichloro-2-(isopropylamino)-1-(.beta.-l-ribofuranosyl)-1h-benzimidazole |
| 01/20/2009 | CA2325633C Steroidal sapogenins and their derivatives for treating alzheimer's disease |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/20/2009 | CA2317008C Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| 01/20/2009 | CA2312795C The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |